Lundgren Erik bought IMUX
May 22, 2026 · Form 4 insider transaction
Lundgren Erik bought 1,000,000 shares of Immunic, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 10 days after the transaction.
Direction
Acquired (buy-side)
Shares
1,000,000
Price
$0.00
Total value
N/A
InsiderLundgren Erik
Role—
CompanyImmunic, Inc. (IMUX)
SecurityStock Option
Transaction codeA: Grant or award
Transaction dateMay 22, 2026
Filing dateJune 1, 2026
Shares owned after1,000,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The options disclosed on this Form 4 are time vested; twenty-five percent (25%) of the shares underlying the options awarded to the Reporting Person will vest on May 22, 2027, and the remaining seventy-five percent (75%) vesting on a monthly basis in thirty-six (36) equal installments, subject to the Reporting Person remaining an employee of Immunic, Inc. in good standing through the relevant vesting date. The Reporting Person became a director and a Section 16 insider on June 1, 2026.